Track topics on Twitter Track topics that are important to you
ROYAL BANK PLAZA, SOUTH TOWER 200 BAY ST, SUITE 3120, BOX 122
Albireo Pharma Inc., through its Elobix subsidiary, entered into an agreement with HealthCare Royalty Partners to monetize its royalty rights for the constipation drug elobixibat in Japan.
The biotech is tapping HealthCare Royalty Partners for $125 million in near-term cash in exchange for royalty payments later.
Immuno-oncology firm Agenus Inc. entered a $230mm royalty sale agreement with Healthcare Royalty Partners, which will pay $190mm in cash up front in exchange for royalties Agenus is eligible to receiv...
La Jolla Pharmaceutical Co. sold tiered royalty rights for its Giapreza (angiotensin II) to HealthCare Royalty Partners in exchange for $125mm.
— Albireo subsidiary eligible to receive up to $60 million under agreement — — Decision on Japanese New Drug Application for elobixibat expected in first half of 2018 — BOSTON, Jan. 03,...
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq:LJPC) (La Jolla), a leader in the discovery, development and commercialization of innovative therapies intended t...
Royalty Pharma acquires Royalty Rights on Global Net Sales of Sacituzumab Govitecan (IMMU-132) Across All Indications for $175 Million Royalty Pharma Acquires $75 Million of Immunomedics Common S...
The societal impact of drug use is well known. An example is when drug-intoxicated drivers increase the burden on policing and healthcare services.
Drug eluting stents are one of the main devices of coronary intervention, which play a therapeutic role through the combination of medical devices. Drug is an important part of the drug eluting stents...
The aim of this study was to develop a strategy to identify adverse drug events associated with drug-drug interactions by analyzing the prescriptions of critically ill patients.
The purpose of this study is to utilize unique qualitative data to determine the effects of sporadic international drug interdictions on drug trafficking, and to assess whether the responses of drug t...
The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session...
Annually, the Department of Anesthesiology, Siriraj hospital has responsibilities to take care of more than 50,000 patients peri-operatively. According to Maslow's hierarchy of needs; huma...
The objective of the study is to evaluate the process of early re-endothelialization of the Coroflex® ISAR Drug-eluting stent compared with the Ultimaster® Drug-eluting stent
The investigators hypothesize that in a real-world population undergoing percutaneous coronary intervention (PCI) for de-novo stenoses in small native vessels with a diameter
The purpose of this study is to determine the safety of AZX100 Drug Product and to determine whether it is effective in preventing or reducing re-growth of surgically removed keloid scars.
A pioneer in the field when launched in 1992, Drug Royalty was the first firm to provide royalty-based financing in the life sciences sector and the first to complete royalty transactions with invento...
Drug Royalty is an innovative and profitable Canadian company involved in the international life science industry. Established in 1992, DRC was designed to participate in the growth from the global he...
DRI is a pioneer and global leader in healthcare royalty investing and has completed transactions with large global pharmaceutical companies, biotechnology companies, universities...
Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalt...
Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purch...
We have published hundreds of DRUG ROYALTY CORPORATION INC news stories on BioPortfolio along with dozens of DRUG ROYALTY CORPORATION INC Clinical Trials and PubMed Articles about DRUG ROYALTY CORPORATION INC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DRUG ROYALTY CORPORATION INC Companies in our database. You can also find out about relevant DRUG ROYALTY CORPORATION INC Drugs and Medications on this site too.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...